Tumor Biology

, Volume 36, Issue 4, pp 3109–3118 | Cite as

Leishmanial sphingolipid induces apoptosis in Sarcoma 180 cancer cells through regulation of tumour growth via angiogenic switchover

  • Subhadip Das
  • Nabanita Chatterjee
  • Dipayan Bose
  • Somenath Banerjee
  • Tarun Jha
  • Krishna Das Saha
Research Article

Abstract

Sphingolipids are membrane and intracellular lipids that typically modulate cellular processes to cause cell death. Exogenous administration of sphingolipids may cause restriction of tumour growth and several alternative strategies are being used to control the cell growth. The microbes, their cellular component(s) or metabolites like DHA, EPA and also FTY720 have been employed as new therapeutic entities to regulate the disease condition. The therapeutic efficacy of lipids from Leishmania donovani in rheumatoid arthritis and also in sepsis condition associated with inflammatory diseases is well established. In this study, we explored the apoptotic effect of LSPL-1 (leishmanial sphingolipid-1) in Sarcoma 180 cells towards the regulation of tumour growth. The study using a panel of cancer cell lines revealed that LSPL-1 induces cell death in Sarcoma 180. The apoptotic changes were assessed by annexin exposure and DNA content analysis using flow cytometry. LSPL-1 appears to activate several pro- and anti-apoptotic molecules through reactive oxygen species (ROS) generation and also caspase activation, as determined by Western blot and ELISA analyses. Simultaneously, it may improve the survival rate of mice bearing tumour induced by Sarcoma 180 cells, with pathological changes. LSPL-1 may also suppress the cancer-associated inflammatory responses with the expression of matrix metalloproteinase having inhibitory role. It may regulate several angiogenic factors including VEGF, Ang-2 and CD34 in angiogenic events generated in Sarcoma 180 cell-induced tumour. These studies underline the significance of anti-neoplastic potential of LSPL-1 through apoptosis induction and abrogation of angiogenic responses in Sarcoma 180 cell-associated tumour.

Keyword

Sphingolipid Apoptosis Tumour Angiogenesis 

Notes

Acknowledgments

The Council of Scientific and Industrial Research, India financially supported this work. The authors convey their sincerest thanks to the Director, Dr. Chitra Mandal of CSIR-Indian Institute of Chemical Biology for providing us the necessary support for this work. We extend our thanks to Dr. Suvendra Nath Bhattacharyya (Indian Institute of Chemical Biology) and Mr. Diptadeep Sarkar for their help in confocal laser-scanning microscopy and Dr S. N. Kabir and Anushila Gangopadhyay for flow cytometry. We are also indebted to Dr. Basudeb Achari and Dr. J. Rajan Vedasiromoni of our institute for critically reviewing the manuscript.

Conflicts of interest

None

References

  1. 1.
    Dyzmann-Sroka A, Malicki J: Cancer incidence and mortality in the greater Poland region-analysis of the year 2010 and future trends. Rep Pract Oncol Radiother;19:296–300Google Scholar
  2. 2.
    Prasad V, Goldstein JA: US news and world report cancer hospital rankings: do they reflect measures of research productivity? PLoS One;9:e107803Google Scholar
  3. 3.
    Raguz S, Yague E. Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer. 2008;99:387–91.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Chakrabarty AM. Microorganisms and cancer: quest for a therapy. J Bacteriol. 2003;185:2683–6.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Wei MQ, Mengesha A, Good D, Anne J. Bacterial targeted tumour therapy—dawn of a new era. Cancer Lett. 2008;259:16–27.CrossRefPubMedGoogle Scholar
  6. 6.
    Zhao X, Wakamatsu Y, Shibahara M, Nomura N, Geltinger C, Nakahara T, et al. Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture. Cancer Res. 1999;59:482–6.PubMedGoogle Scholar
  7. 7.
    Bachmeier BE, Iancu CM, Jochum M, Nerlich AG. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther. 2005;5:149–63.CrossRefPubMedGoogle Scholar
  8. 8.
    Andrieu-Abadie N, Gouaze V, Salvayre R, Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic Biol Med. 2001;31:717–28.CrossRefPubMedGoogle Scholar
  9. 9.
    Baumruker T, Prieschl EE. Sphingolipids and the regulation of the immune response. Semin Immunol. 2002;14:57–63.CrossRefPubMedGoogle Scholar
  10. 10.
    Maceyka M, Spiegel S: Sphingolipid metabolites in inflammatory disease. Nature;510:58–67Google Scholar
  11. 11.
    Ng Y, Barhoumi R, Tjalkens RB, Fan YY, Kolar S, Wang N, et al. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis. 2005;26:1914–21.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Heimli H, Hollung K, Drevon CA. Eicosapentaenoic acid-induced apoptosis depends on acyl CoA-synthetase. Lipids. 2003;38:263–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, et al. Selective cancer cell apoptosis induced by fty720; evidence for a bcl-dependent pathway and impairment in erk activity. Anticancer Res. 2003;23:3183–93.PubMedGoogle Scholar
  14. 14.
    Das S, Chatterjee N, Bose D, Banerjee S, Pal P, Jha T, Das Saha K: Lipid isolated from a Leishmania donovani strain reduces Escherichia coli induced sepsis in mice through inhibition of inflammatory responses. Mediat Inflamm;2014:409694Google Scholar
  15. 15.
    Majumdar KN, Banerjee A, Ratha J, Mandal M, Sarkar RN, Saha KD. Leishmanial lipid suppresses tumor necrosis factor alpha, interleukin-1beta, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial-mediated pathway. Arthritis Rheum. 2008;58:696–706.CrossRefPubMedGoogle Scholar
  16. 16.
    Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Dasgupta S, Hogan EL. Chromatographic resolution and quantitative assay of cns tissue sphingoids and sphingolipids. J Lipid Res. 2001;42:301–8.PubMedGoogle Scholar
  18. 18.
    Bischel MD, Austin JH. A modified benzidine method for the chromatographic detection of sphingolipids and acid polysaccharides. Biochim Biophys Acta. 1963;70:598–600.CrossRefPubMedGoogle Scholar
  19. 19.
    Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.CrossRefPubMedGoogle Scholar
  20. 20.
    Das S, Chatterjee N, Bose D, Dey SK, Munda RN, Nandy A, Bera S, Biswas SK, Das Saha K: Anticancer potential of 3-(arylideneamino)-2-phenylquinazoline-4(3H)-one derivatives. Cell Physiol Biochem, 29:251–260Google Scholar
  21. 21.
    Pramanik M, Chatterjee N, Das S, Saha KD, Bhaumik A: Anthracene-bisphosphonate based novel fluorescent organic nanoparticles explored as apoptosis inducers of cancer cells. Chem Commun (Camb);49:9461–9463.Google Scholar
  22. 22.
    Mandal SCN, Das S, Saha KD, Chaudhuri K. Magnetic core-shell nanoprobe for sensitive killing of cancer cells via induction with a strong external magnetic field. RSC Adv. 2014;39:20077–85.CrossRefGoogle Scholar
  23. 23.
    Chatterjee N, Das S, Bose D, Banerjee S, Jha T, Saha KD: Leishmanial lipid suppresses the bacterial endotoxin-induced inflammatory response with attenuation of tissue injury in sepsis. J Leukoc Biol;96:325–336.Google Scholar
  24. 24.
    Ji DB, Ye J, Jiang YM, Qian BW: Anti-tumor effect of liqi, a traditional chinese medicine prescription, in tumor bearing mice. BMC Complement Altern Med 2009;9:20Google Scholar
  25. 25.
    Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med. 2003;34:1–10.CrossRefPubMedGoogle Scholar
  26. 26.
    Minton NP. Clostridia in cancer therapy. Nat Rev Microbiol. 2003;1:237–42.CrossRefPubMedGoogle Scholar
  27. 27.
    Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A. 2001;98:15155–60.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975;72:3666–70.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Saltzman DA, Heise CP, Hasz DE, Zebede M, Kelly SM, Curtiss 3rd R, et al. Attenuated Salmonella typhimurium containing interleukin-2 decreases mc-38 hepatic metastases: a novel anti-tumor agent. Cancer Biother Radiopharm. 1996;11:145–53.CrossRefPubMedGoogle Scholar
  30. 30.
    Liu Q, Zhao X, Frissora F, Ma Y, Santhanam R, Jarjoura D, et al. Fty720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood. 2008;111:275–84.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Wallington-Beddoe CT, Hewson J, Bradstock KF, Bendall LJ: Fty720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy;7:707–715Google Scholar
  32. 32.
    Fu SL, Wallner SR, Bowne WB, Hagler MD, Zenilman ME, Gross R, et al. Sophorolipids and their derivatives are lethal against human pancreatic cancer cells. J Surg Res. 2008;148:77–82.CrossRefPubMedGoogle Scholar
  33. 33.
    Hardin R, Pierre J, Schulze R, Mueller CM, Fu SL, Wallner SR, et al. Sophorolipids improve sepsis survival: effects of dosing and derivatives. J Surg Res. 2007;142:314–9.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Subhadip Das
    • 1
  • Nabanita Chatterjee
    • 1
  • Dipayan Bose
    • 1
  • Somenath Banerjee
    • 1
  • Tarun Jha
    • 2
  • Krishna Das Saha
    • 1
  1. 1.Cancer Biology & Inflammatory Disorder DivisionCSIR-Indian Institute of Chemical BiologyKolkataIndia
  2. 2.Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical TechnologyJadavpur UniversityKolkataIndia

Personalised recommendations